Ajit Gill - Net Worth and Insider Trading
Ajit Gill Net Worth
The estimated net worth of Ajit Gill is at least $58,426 dollars as of 2025-04-23. Ajit Gill is the Former Director, Pres. & CEO of Nektar Therapeutics and owns about 87,991 shares of Nektar Therapeutics (NKTR) stock worth over $58,426. Details can be seen in Ajit Gill's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Ajit Gill has not made any transactions after 2006-03-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Ajit Gill
Ajit Gill Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ajit Gill owns 1 companies in total, including Nektar Therapeutics (NKTR) .
Click here to see the complete history of Ajit Gill’s form 4 insider trades.
Insider Ownership Summary of Ajit Gill
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NKTR | Nektar Therapeutics | 2006-03-23 | director & CEO & President |
Ajit Gill Latest Holdings Summary
Ajit Gill currently owns a total of 1 stock. Ajit Gill owns 87,991 shares of Nektar Therapeutics (NKTR) as of March 23, 2006, with a value of $58,426.
Latest Holdings of Ajit Gill
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| NKTR | Nektar Therapeutics | 2006-03-23 | 87,991 | 0.66 | 58,426 |
Holding Weightings of Ajit Gill
Ajit Gill Form 4 Trading Tracker
According to the SEC Form 4 filings, Ajit Gill has made a total of 0 transactions in Nektar Therapeutics (NKTR) over the past 5 years. The most-recent trade in Nektar Therapeutics is the sale of 3,545 shares on March 23, 2006, which brought Ajit Gill around $69,518.
Insider Trading History of Ajit Gill
- 1
Ajit Gill Trading Performance
Ajit Gill Ownership Network
Ownership Network List of Ajit Gill
Ownership Network Relation of Ajit Gill
Ajit Gill Owned Company Details
What does Nektar Therapeutics do?
Who are the key executives at Nektar Therapeutics?
Ajit Gill is the director & CEO & President of Nektar Therapeutics. Other key executives at Nektar Therapeutics include SVP & General Counsel Mark Andrew Wilson , Chief R&D Officer Jonathan Zalevsky , and director & President & CEO Howard W Robin .
Nektar Therapeutics (NKTR) Insider Trades Summary
Over the past 18 months, Ajit Gill made no insider transaction in Nektar Therapeutics (NKTR). Other recent insider transactions involving Nektar Therapeutics (NKTR) include a net sale of 243,523 shares made by Howard W Robin , a net sale of 102,081 shares made by Jonathan Zalevsky , and a net sale of 94,105 shares made by Mark Andrew Wilson .
In summary, during the past 3 months, insiders sold 45,114 shares of Nektar Therapeutics (NKTR) in total and bought 0 shares, with a net sale of 45,114 shares. During the past 18 months, 515,209 shares of Nektar Therapeutics (NKTR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 515,209 shares.
Nektar Therapeutics (NKTR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Nektar Therapeutics Insider Transactions
Ajit Gill Mailing Address
Above is the net worth, insider trading, and ownership report for Ajit Gill. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Ajit Gill's mailing address is: San Carlos Ca 94070.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
